Tom Soloway brings over 25 years of experience in the life sciences industry, with senior roles in strategy, operations, corporate finance and venture capital. He joins T-knife from Audentes Therapeutics, a gene therapy company focused on developing and commercializing innovative products for patients living with serious, life-threatening rare neuromuscular diseases, where he most recently served as Executive Vice President, Chief Operating Officer. Previously, Tom served as Senior Vice President, Chief Financial Officer of Ascendis Pharma A/S, a biopharmaceutical company that utilizes its proprietary TransCon technology platform to address unmet needs in the fields of endocrinology and oncology.
Prior to Ascendis, Tom co-founded Transcept Pharmaceuticals, Inc., where he held positions of increasing responsibility, serving initially as Senior Vice President, Operations and Chief Financial Officer and subsequently as Executive Vice President, Chief Operating Officer. Prior to Transcept, Tom was a Principal at Montreux Equity Partners, a venture capital firm focused on providing growth capital for early-stage healthcare and life sciences companies. He holds a B.S. in Entrepreneurial Studies from the University of Southern California and an M.B.A. from Georgetown University.